A Look at Crane Co (CR) After 3.7% Gain -- GF Value $204.05 vs Price $226.14
On July 24, 2026, Crane Co (CR) shares rose 3.7% to a current price of $226.14. This movement is notable within a 52-week range of $159.58 to $226.99, reflectin
CR - Crane Company
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$244.33
DETAILS
HIGH:
$253.00
LOW:
$238.00
MEDIAN:
$242.00
CONSENSUS:
$244.33
UPSIDE:
8.04%
Stock News
This Crane Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Crane (NYSE:CR) Given Average Recommendation of “Buy” by Brokerages
Shares of Crane (NYSE: CR - Get Free Report) have earned a consensus recommendation of "Buy" from the eight analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and two have given a strong buy recommendation to the company.
Crane NXT Announces Dates for Second Quarter 2026 Earnings Release and Earnings Call
WALTHAM, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a global leader in authentication and traceability technologies, today announced its schedule for the company's second quarter 2026 results.
Crane Company Announces Date for Second Quarter 2026 Earnings Release and Teleconference
STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE: CR) announces the following schedule and teleconference information for its second quarter 2026 earnings release: Earnings Release: July 28, 2026 after close of market by public distribution and the Crane Company website at www.craneco.com. Teleconference: July 29, 2026 at 10:00 AM (Eastern) hosted by Alex Alcala, President & CEO, and Richard A. Maue, Executive Vice President & CFO. The call can be accessed in a listen-only mode via.
Headwater Gold Announces Commencement of Centerra-Funded Drilling at Crane Creek Project, Idaho
Vancouver, British Columbia – TheNewswire - June 29, 2026: Headwater Gold Inc. (CSE: HWG) (OTCQX: HWAUF) (the “Company” or “Headwater”) is pleased to announce that Centerra Gold Inc. (“Centerra”) (TSX: CG) has commenced drilling at Headwater's Crane Creek Project (“Crane Creek” or the “Project”) in western Idaho. The drill program is being operated and fully funded by Centerra pursuant to the earn-in agreement announced on December 3, 2025 . Highlights:
BRIXMOR PROPERTY GROUP ISSUES ANNUAL CORPORATE RESPONSIBILITY REPORT
NEW YORK, June 18, 2026 /PRNewswire/ -- Brixmor Property Group Inc. (NYSE: BRX) ("Brixmor" or the "Company") announced today the release of its eighth annual Corporate Responsibility (CR) Report, which provides a comprehensive overview of the Company's CR strategy, initiatives, and 2025 performance. "This report highlights how central Corporate Responsibility is to how we operate and grow," stated Brian Finnegan, Chief Executive Officer and President.
enGene Reports Second Quarter 2026 Financial Results and Provides Business Update
enGene Therapeutics Inc. (Nasdaq: ENGN, âenGeneâ or the âCompanyâ), a clinical-stage, non-viral genetic medicines company today announced its financial
Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcoritamab, a T-cell engaging antibody administered subcutaneously
Implied Volatility Surging for Crane Company Stock Options
Investors need to pay close attention to CR stock based on the movements in the options market lately.
ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States
ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a commercial-stage immunotherapy company, today announced an exclusive U.S. Development and Supply Agreement wit
Crane Co (CR) Stock Down 4.1% -- Now Undervalued? GF Score: 86/100
On May 15, 2026, Crane Co (CR) shares fell 4.1% to a current price of $172.19. This decline comes in the context of a 52-week range that saw a high of $214.31 a
Crane NXT Q1 Earnings Call Highlights
Crane NXT NYSE: CXT reported first-quarter 2026 sales growth and reaffirmed its earnings outlook while updating its full-year guidance to include the recently completed acquisition of Antares Vision.
Crane NXT Reports First Quarter 2026 Results
Completes Acquisition of Antares Vision, a Global Leader in Inspection, Detection, and Track & Trace Technologies Delivers Organic Sales Growth of 6%; Maintains Full Year EPS Guidance of $4.10 to $4.40 WALTHAM, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT) ("Crane NXT" or the "Company"), a global leader in authentication and traceability technologies, today announced its financial results for the first quarter ended March 31, 2026.
Crane Co (CR) Stock Down 3.1% -- Now Undervalued? GF Score: 87/100
On May 01, 2026, Crane Co (CR) shares fell 3.1% to $172.24. This decline comes amid a 52-week trading range of $159.58 to $214.31, indicating some volatility in
Crane Company (CR) Q1 2026 Earnings Call Transcript
Crane Company (CR) Q1 2026 Earnings Call Transcript
Crane Company Reports First Quarter 2026 Results and Raises Full Year EPS Guidance
STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company ("Crane," NYSE:CR) today announced its financial results for the first quarter of 2026 and raised its full year adjusted EPS outlook. Alex Alcala, Crane's President and Chief Executive Officer, stated: "We delivered a very strong start to 2026, generating 15% adjusted EPS growth in the first quarter. Results exceeded our expectations with the majority of our outperformance driven by outstanding execution and momentum across our recent acquisitions.
Crane Company Announces Completion of CEO Succession
STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE: CR) today announced the completion of its previously disclosed CEO succession plan, effective April 27, 2026. Mr. Alex Alcala has assumed the role of President and Chief Executive Officer, succeeding Mr. Max Mitchell, who has transitioned to the role of Executive Chairman, as planned. Mr. Alcala brings thirteen years of experience within Crane and deep knowledge of the Company's markets, operations, and strategic priorities. During his tenu.
Crane (NYSE:CR) versus EnWave (OTCMKTS:NWVCF) Financial Contrast
Crane (NYSE: CR - Get Free Report) and EnWave (OTCMKTS:NWVCF - Get Free Report) are both industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends. Analyst Ratings This is a summary of current ratings and
State of Alaska Department of Revenue Has $902,000 Position in Crane $CR
State of Alaska Department of Revenue lowered its stake in shares of Crane (NYSE: CR) by 54.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,892 shares of the conglomerate's stock after selling 5,869 shares during the quarter.
Price Targets
Crane price target raised to $242 from $215 at Stifel
$242.00
(was $217.49)
Nathan Jones
·
Stifel Nicolaus
BMO Capital Starts Crane (CR) at Outperform
$253.00
(was $217.49)
Daniel DiCicco
·
BMO Capital
Crane upgraded to Buy from Hold at Stifel
$215.00
(was $177.93)
Nathan Jones
·
Stifel Nicolaus
Crane price target raised to $238 from $235 at Deutsche Bank
$238.00
(was $178.01)
Deutsche Bank
Crane price target raised to $201 from $200 at Stifel
$201.00
(was $204.03)
Nathan Jones
·
Stifel Nicolaus
Crane price target lowered to $200 from $202 at Stifel
$200.00
(was $186.50)
Stifel Nicolaus
Crane initiated with an Outperform at Wolfe Research
$215.00
(was $184.03)
Wolfe Research
Crane price target raised to $235 from $230 at DA Davidson
$235.00
(was $193.18)
D.A. Davidson
Crane price target raised to $202 from $200 at Stifel
$202.00
(was $191.29)
Stifel Nicolaus
DA Davidson Reiterates Buy Rating on Crane (CR)
$230.00
(was $194.20)
Matt Summerville
·
D.A. Davidson
Crane price target raised to $215 from $190 at UBS
$215.00
(was $186.67)
Damian Karas
·
UBS
Crane price target lowered to $186 from $206 at Deutsche Bank
$186.00
(was $141.30)
Scott Deuschle
·
Deutsche Bank
Crane price target raised to $175 from $168 at Stifel
$175.00
(was $159.14)
Nathan Jones
·
Stifel Nicolaus
Crane price target raised to $182 from $175 at Deutsche Bank
$182.00
(was $156.60)
Scott Deuschle
·
Deutsche Bank
DA Davidson Reiterates Buy Rating on Crane (CR)
$160.00
(was $145.58)
Matt Summerville
·
D.A. Davidson
UBS Maintains Buy on Crane, Lowers Price Target to $125
$125.00
(was $93.84)
UBS